REGN 241122 750.00C (REGN241122C750000) Stock Options, News & Quotes

US OptionsDetailed Quotes

REGN241122C750000

Watchlist

0.50
-5.78-92.04%

15min DelayClose Nov 22 16:00 ET

2.80High0.50Low

Intraday

5D
Daily

News

Regeneron Pharmaceuticals (NASDAQ:REGN) Shareholders Have Earned a 15% CAGR Over the Last Five Years
Yahoo FinanceNov 23 09:00 ET
Pfizer Meets Amyloidosis Rival as BridgeBio Wins FDA Nod for Attruby
Seeking AlphaNov 23 08:26 ET
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Kevin TraversNov 22 16:17 ET
Catalyst Watch: Robotaxi IPO, OPEC+, Holiday Shopping Data, and Movie Blockbusters
Seeking AlphaNov 22 15:00 ET
Market Climbs, Bitcoin Close to $100k | Live Stock
Kevin TraversNov 22 11:06 ET
Bitcoin Hits $99k, Thursday Market Whiplash Following Nvidia Price | Wall Street Today
Kevin TraversNov 21 16:09 ET

Comments

70825143

Nov 22 16:05

$Regeneron Pharmaceuticals (REGN.US)$ Fuck you, REGN

NathanRobert

Nov 13 15:03

5 Quality Stocks That Are Undervalued

🔥 We go over 5 stocks that look undervalued, i show you the numbers for yourself, i own 1 of the stocks on the list, but i try to go over stocks you’ve probably never heard of before! LMK ur thoughts :)
$Hershey (HSY.US)$ $Celsius Holdings (CELH.US)$ $Regeneron Pharmaceuticals (REGN.US)$ $Yelp Inc (YELP.US)$ $Innovative Industrial Properties Inc (IIPR.US)$

https://youtu.be/4qd-58cBqi4

From YouTube

10xStockPicks

Oct 24 07:55

Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable

Esperion $Esperion Therapeutics (ESPR.US)$ We reiterate Strong Buy rating. Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 million Americans take statin drugs, we see continued prescription growth & expect over 5...

+20

Meltyy

Sep 25 06:31

See FDA PDUFA update 👀 👇

🚨 This Week’s PDUFAs:
$Heron Therapeutics (HRTX.US)$ : 🤔
⇨ ZYNRELEF® Vial Access Needle
‣ Postoperative pain
‣ PDUFA: 9/23/24 (sNDA)
$Bristol-Myers Squibb (BMY.US)$ : 🤔
⇨ KarXT (xanomeline-trospium)
‣ Schizophrenia
‣ PDUFA: 9/26/24 (NDA)
$Sanofi (SNY.US)$ $Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Dupixent
‣ Chronic obstructive pulmonary disease
‣ PDUFA: 9/27/24 (sBLA)
$BeiGene (BGNE.US)$ $Merck & Co (MRK.US)$ & $Bristol-Myers Squibb (BMY.US)$ : 🤔
⇨ Tislelizumab, KEYTRUDA, OPDIVO & YER...